Truist upgraded Sangamo (SGMO) to Buy from Hold with a $7 price target The firm says that with the company’s expenses streamlined, the shares could see potential upside in the next 12-18 months with more business development adding non-dilutive funding. Over the past year, Sangamo has right-sized its cost basis, refocused its research and development and is advancing its pipeline to enhance the company’s financial positioning, the analyst tells investors in a research note.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGMO: